FDA Approves Gen-Probe's PROGENSA® PCA3 Assay, First Urine-Based Molecular Test to Help Determine Need for Repeat Prostate Biopsies

-- Test May Help Reduce Unnecessary Repeat Prostate Biopsies --

Summary:

FDA Approves Gen-Probe’s PROGENSA® PCA3 Assay, First Urine-Based Molecular Test to Help Determine Need for Repeat Prostate Biopsies

Date: 16 February 2012, 10:52 AM EST
Source: Gen-Probe Incorporated
Related Sites: http://www.gen-probe.com
Show/Hide more...

Social Media Tools:


Click asset titles for downloads, embeds and more...

Video

FDA Approves Gen-Probe’s PROGENSA® PCA3 Assay, First Urine-Based Molecular Test to Help Determine Need for Repeat Prostate Biopsies Video
Click asset titles for downloads, embeds and more...

Photos

Gen-Probe’s PROGENSA PCA3 test received FDA approval
Photo#1
PROGENSA PCA3 assay is the first urine-based test to help determine the need for repeat biopsies in men who have had a previous negative biopsy.
Photo#2
San Diego-based Gen-Probe, a leader in molecular diagnostics, received FDA approval for its PROGENSA PCA3 assay.
Photo#3

Subscribe via RSS

RSSAll Content
RSSConsumer
RSSEntertainment
RSSFinancial
RSSGovernment
RSSHealthcare
RSSRetail
RSSTechnology

Register

Journalists who register may create email subscriptions to search results and a cart of assets to download. Click here to login, register or edit profile.

What Our Users
Are Saying

"I like the way the DC is easy to navigate, easy to find stories, easy to find when they were filed so you know if they’re out of date, and easy to see an on-line version of the available video" -- Allan C Lee, Director of News and Current Affairs